4,092 research outputs found

    A Bayesian Periodogram Finds Evidence for Three Planets in 47 Ursae Majoris

    Full text link
    A Bayesian analysis of 47 Ursae Majoris (47 UMa) radial velocity data confirms and refines the properties of two previously reported planets with periods of 1079 and 2325 days and finds evidence for an additional long period planet with a period of approximately 10000 days. The three planet model is found to be 10^5 times more probable than the next most probable model which is a two planet model. The nonlinear model fitting is accomplished with a new hybrid Markov chain Monte Carlo (HMCMC) algorithm which incorporates parallel tempering, simulated annealing and genetic crossover operations. Each of these features facilitate the detection of a global minimum in chi-squared. By combining all three, the HMCMC greatly increases the probability of realizing this goal. When applied to the Kepler problem it acts as a powerful multi-planet Kepler periodogram. The measured periods are 1078 \pm 2, 2391{+100}{-87}, and 14002{+4018}{-5095}d, and the corresponding eccentricities are 0.032 \pm 0.014, 0.098{+.047}{-.096}, and 0.16{+.09}{-.16}. The results favor low eccentricity orbits for all three. Assuming the three signals (each one consistent with a Keplerian orbit) are caused by planets, the corresponding limits on planetary mass (M sin i) and semi-major axis are (2.53{+.07}{-.06}MJ, 2.10\pm0.02au), (0.54\pm0.07MJ, 3.6\pm0.1au), and (1.6{+0.3}{-0.5}MJ, 11.6{+2.1}{-2.9}au), respectively. We have also characterized a noise induced eccentricity bias and designed a correction filter that can be used as an alternate prior for eccentricity, to enhance the detection of planetary orbits of low or moderate eccentricity

    Waterdock 2.0: Water placement prediction for Holo-structures with a pymol plugin.

    Get PDF
    Water is often found to mediate interactions between a ligand and a protein. It can play a significant role in orientating the ligand within a binding pocket and contribute to the free energy of binding. It would thus be extremely useful to be able to accurately predict the position and orientation of water molecules within a binding pocket. Recently, we developed the WaterDock protocol that was able to predict 97% of the water molecules in a test set. However, this approach generated false positives at a rate of over 20% in most cases and whilst this might be acceptable for some applications, in high throughput scenarios this is not desirable. Here we tackle this problem via the inclusion of knowledge regarding the solvation structure of ligand functional groups. We call this new protocol WaterDock2 and demonstrate that this protocol maintains a similar true positive rate to the original implementation but is capable of reducing the false-positive rate by over 50%. To improve the usability of the method, we have also developed a plugin for the popular graphics program PyMOL. The plugin also contains an implementation of the original WaterDock.GAR is supported by the Memorial Sloan Kettering Cancer Center, NIH grant P30 CA008748

    Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development

    Get PDF
    Negative symptoms have long been considered a core component of schizophrenia. Modern conceptualizations of the structure of negative symptoms posit that there are at least two broad dimensions (motivation and pleasure and diminished expression) or perhaps five separable domains (avolition, anhedonia, asociality, blunted affect, alogia). The current review synthesizes a body of emerging research indicating that avolition may have a special place among these dimensions, as it is generally associated with poorer outcomes and may have distinct neurobiological mechanisms. Network analytic findings also indicate that avolition is highly central and interconnected with the other negative symptom domains in schizophrenia, and successfully remediating avolition results in global improvement in the entire constellation of negative symptoms. Avolition may therefore reflect the most critical treatment target within the negative symptom construct. Implications for targeted treatment development and clinical trial design are discussed
    corecore